搜索页_+Lapatinib

设为首页

收藏本站

网站地图 | English | 公务邮箱

读者指南

学术客户端

NSTL服务站

科技查新

常用资源

在“Elsevier电子期刊”中，命中：306条，耗时：小于0.01 秒

1.Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer

作者：Wen-Ji Zhang^a ; Yong Li^b ; Meng-Ning Wei^a ; Yao Chen^a ; Jian-Ge Qiu^a ; Qi-Wei Jiang^a ; Yang Yang^a ; Di-Wei Zheng^a ; Wu-Ming Qin^a ; Jia-Rong Huang^a ; Kun Wang^a ; Wen-Juan Zhang^c ; Yi-Jun Wang^d ; Dong-Hua Yang^d ; Zhe-Sheng Chen^d ; ^e ; ^{chenz@stjohns.edu} ; Zhi Shi^a ; ^{tshizhi@jnu.edu.cn}

关键词：Regorafenib ; Lapatinib ; Targeted therapy ; Combination chemotherapy ; Colorectal cancer

刊名：Cancer Letters

出版年：2017

2.Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy

关键词：Lapatinib ; Early breast cancer ; Adjuvant ; Hormone receptor

刊名：European Journal of Cancer

出版年：2016

3.Niclosamide inhibits epithelial-mesenchymal transition and tumor growth in lapatinib-resistant human epidermal growth factor receptor 2-positive breast cancer

作者：Junjun Liu^a ; ^b ; Xiaosong Chen^a ; ^b ; Toby Ward^b ; Yan Mao^a ; Jessica Bockhorn^b ; Xiaofei Liu^b ; Gen Wang^a ; Mark Pegram^b ; ^{mpegram@stanford.edu" class="auth_mail" title="E-mail the corresponding author} ; Kunwei Shen^a ; ^{kwshen@medmail.com.cn" class="auth_mail" title="E-mail the corresponding author}

关键词：Human epidermal growth factor receptor 2 ; Breast cancer ; Lapatinib resistance ; Epithelial-mesenchymal transition ; Niclosamide

刊名：International Journal of Biochemistry and Cell Biology

出版年：2016

4.Pigmentation of the tongue with lapatinib treatment in a patient with advanced breast cancer: A case report

作者：Matthew D. Bloom ^{mdbloom4@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Joseph M. Gibney ^{josephmgibney@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Coy D. Heldermon ; ^{coy.heldermon@medicine.ufl.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：Lapatinib ; EGFR ; Pigmentation ; Tongue

刊名：Cancer Treatment Communications

出版年：2016

5.A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

作者：Henry L. Gó ; mez¹ ; Silvia Neciosup¹ ; Cé ; lia Tosello² ; Max Mano³ ; José ; Bines⁴ ; Gustavo Ismael⁵ ; Patrí ; cia X. Santi⁶ ; Hé ; lio Pinczowski⁶ ; Yeni Neró ; n⁷ ; Marcello Fanelli⁸ ; Luis Fein⁹ ; Carlos Sampaio¹⁰ ; Guillermo Lerzo¹¹ ; Adolfo Capó ; ¹² ; Juan J. Zarba¹³ ; Cé ; sar Blajman¹⁴ ; Mirta S. Varela¹⁵ ; Jeovany Martí ; nez-Mesa¹⁶ ; Gustavo Werutsky¹⁶ ; ^{gustavo.werutsky@lacog.org.br" class="auth_mail" title="E-mail the corresponding author} ; Carlos H. Barrios¹⁷

关键词：Chemotherapy ; Human epidermal growth factor receptor 2-positive ; Lapatinib ; Metastatic breast cancer ; Treatment outcome

刊名：Clinical Breast Cancer

出版年：2016

6.Characterization of the binding of an anticancer drug, lapatinib to human serum albumin

作者：Md. Zahirul Kabir^a ; Abdul Kadir Mukarram^b ; Saharuddin B. Mohamad^b ; ^c ; Zazali Alias^a ; Saad Tayyab^a ; ^c ; ^{saadtayyab2004@yahoo.com" class="auth_mail" title="E-mail the corresponding author}

关键词：Lapatinib ; Human serum albumin ; Drug&ndash ; protein interaction ; Fluorescence quenching ; Molecular docking

刊名：Journal of Photochemistry and Photobiology B: Biology

出版年：2016

7.A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer

作者：Neil M. Iyengar ; ^{iyengarn@mskcc.org" class="auth_mail" title="E-mail the corresponding author} ; Monica N. Fornier ; Steven M. Sugarman ; Maria Theodoulou ; Tiffany A. Troso-Sandoval ; Gabriella M. D'Andrea ; Pamela R. Drullinsky ; Devika Gajria ; Shari B. Goldfarb ; Elizabeth A. Comen ; Diana E. Lake ; Shanu Modi ; Tiffany A. Traina ; Mario E. Lacouture ; Melanie F. Chen ; Sujata Patil ; José ; Baselga ; Larry Norton ; Clifford A. Hudis ; Chau T. Dang

关键词：ALTTO ; Dose-dense chemotherapy ; Dose schedule ; Drug toxicity ; Taxane

刊名：Clinical Breast Cancer

出版年：2016

8.The role of tyrosine kinase inhibitor “Lapatinib‿in pulmonary hypertension

作者：Yaser Alkhatib^a ; ^{Yalkhat1@hfhs.org" class="auth_mail" title="E-mail the corresponding author} ; Derar Albashaireh^b ; Tameem Al-Aqtash^c ; Rana Awdish^d

关键词：Pulmonary hypertension ; Lapatinib ; Tyrosine kinase inhibitors

刊名：Pulmonary Pharmacology & Therapeutics

出版年：2016

9.Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer

作者：Mark Abramovitz¹ ; Casey Williams² ; Sibylle Loibl³ ; ^{sibylle.loibl@gbg.de" class="auth_mail" title="E-mail the corresponding author} ; Brian Leyland-Jones² ; ^{bleylandj@aol.com" class="auth_mail" title="E-mail the corresponding author}

关键词：HER-2 positive ; Lapatinib ; Neoadjuvant ; PAM50 ; Trastuzumab

刊名：Clinical Breast Cancer

出版年：2016

10.Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib

作者：Martina Tilio^a ; ¹ ; Valentina Gambini^a ; ¹ ; Junbiao Wang^a ; ¹ ; Chiara Garulli^a ; Cristina Kalogris^a ; Cristina Andreani^a ; Caterina Bartolacci^a ; Maria Elexpuru Zabaleta^a ; Lucia Pietrella^a ; Albana Hysi^b ; Manuela Iezzi^b ; Barbara Belletti^c ; Fiorenza Orlando^d ; Mauro Provinciali^d ; Roberta Galeazzi^e ; Cristina Marchini^a ; ¹ ; ^{cristina.marchini@unicam.it" class="auth_mail" title="E-mail the corresponding author} ; Augusto Amici^a ; ¹ ; ^{augusto.amici@unicam.it" class="auth_mail" title="E-mail the corresponding author}

关键词：HER2 isoform ; Breast cancer ; Δ16HER2 mice ; Targeted therapies ; Drug resistances

刊名：Cancer Letters

出版年：2016

按检索点细分(306)

题名(156)

关键词(99)

文摘(200)

按出版年细分(306)

2027年及以后(24)

2017年(1)

2016年(27)

2015年(21)

2013年(33)

2012年(35)

2011年(34)

2010年(24)

2009年(36)

2008年(33)

2007年(22)

2006年(10)

2005年(3)

2000年及以前(3)

常见问题　|　交通位置　|　联系我们　|　OA远程办公

地址：北京市海淀区学院路29号邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700